Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$8.93bn	142.57	n/a
MSBMesoblast	AU$2.06bn	n/a	n/a
OPTOpthea	AU$738.75m	n/a	n/a
CU6Clarity Pharmaceuticals	AU$734.66m	n/a	n/a
PYCPYC Therapeutics	AU$699.91m	n/a	n/a
IMMImmutep	AU$378.45m	n/a	n/a
DXBDimerix	AU$267.78m	n/a	n/a
CGSCogstate	AU$232.09m	20.33	n/a
IMUImugene	AU$193.42m	n/a	n/a
RACRace Oncology	AU$173.71m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$120.72m	n/a	n/a
ALAArovella Therapeutics	AU$104.88m	n/a	n/a
ACWActinogen Medical	AU$87.72m	n/a	n/a
AGNArgenica Therapeutics	AU$86.46m	n/a	n/a
SNTSyntara	AU$77.38m	n/a	n/a
LTPLtr Pharma	AU$70.58m	n/a	n/a
PEBPacific Edge	NZ$70.64m	n/a	n/a
GD8GO-DX (Aust)	AU$61.94m	n/a	n/a
PIQProteomics International Laboratories	AU$49.78m	n/a	n/a
BXNBioxyne	AU$49.18m	18.18	n/a